Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosis
Not Applicable
- Conditions
- Amyotrophic Lateral Sclerosis (ALS)
- Registration Number
- JPRN-UMIN000024854
- Lead Sponsor
- Okayama university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Severe renal dysfunction (Cr > 3.0 mg/dl) and impossible evaluations for motor functions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We evaluate the effects of edaravone for oxidative stress, anti-oxidative stress and vascular endothelial function in ALS patients.
- Secondary Outcome Measures
Name Time Method